Nimodipine api
66085-59-4
QD
Micronized powder: 15kg/bucket; Regular particle size: 25kg/bucket
2026-08-09
API,Pharmaceutical intermediates,Fine chemicals,Custom compound synthesis
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceCrystalline Solid
Solid
Nimodipine is a dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. It has a role as an antihypertensive agent, a calcium channel blocker, a vasodilator agent and a cardiovascular drug. It is a dihydropyridine, a C-nitro compound, a diester, a member of dicarboxylic acids and O-substituted derivatives, a 2-methoxyethyl ester and an isopropyl ester.|Nimodipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nimodipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Compared to other calcium channel blocking agents, nimodipine exhibits greater effects on cerebral circulation than on peripheral circulation. Nimodipine is used to as an adjunct to improve the neurologic outcome following subarachnoid hemorrhage from ruptured intracranial aneurysm.|Nimodipine is a second generation calcium channel blocker used in the treatment of cerebral vasospasm after subarachnoid hemorrhage. Nimodipine is not widely used and has not been implicated in causing clinically apparent acute liver injury.|A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.Basic Info-
Product Name:
Nimodipine
Other Name:3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-(2-methoxyethyl) 5-(1-methylethyl) ester;3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester;Nimodipine;BAY-e 9736;Nimotop;(±)-Nimodipine;Nimodipine AP;Periplum;Admon;Nemotan;3-O-(2-Methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;82219-46-3;155861-30-6;1301253-68-8
CAS No.:66085-59-4
Molecular Formula:C21H26N2O7
InChIKeys:InChIKey=UIAGMCDKSXEBJQ-UHFFFAOYSA-N
Molecular Weight:418.44
Exact Mass:418.44
EC Number:266-127-0
NSC Number:758476
DSSTox ID:DTXSID5023370
ATC Code:C08CA06|C - Cardiovascular system
HScode:29333990
Categories:
Characteristics-
PSA:
120
XLogP3:2.7
Appearance:white solid
Density:1.3268 (rough estimate)
Melting Point:125 °C
Boiling Point:526.3°C at 760 mmHg
Flash Point:277.3ºC
Refractive Index:1.561
Water Solubility:methanol: 62.5 mg/mL
Storage Conditions:Store at RT
Toxicity:LD50 in mice, rats (mg/kg): 3562, 6599 orally; 33, 16 i.v. (Schlüter)
Collision Cross Section:197.8 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]
Hazard IdentificationClassification of the substance or mixture
Specific target organ toxicity â repeated exposure, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H373 May cause damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P319 Get medical help if you feel unwell.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
API,Pharmaceutical intermediates,Fine chemicals,Custom compound synthesis
-
Location:
1004, No.818A 9, Linzi Avenue, Linzi District, Zibo City, Shandong Province, China
-
Payment Terms:
TT against copy of documents,L/C,100% TT in advance
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
5-10
-
Year of Establishment:
2017
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
